Doping, Juicing, and Executive Bypass Oversight: A Case Study of Major League Baseball's Steroid Scandal
Publication | 10.15.04
Insights
Publication | 09.03.25
Publication | 08.27.25
False Claims Act Qui Tam Actions Won’t Doom Public Universities
Publication | 08.22.25
Antitrust Probes of Classified Intel Require A Delicate Balance
